AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Compugen Ltd
XNAS · usd
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG001S5PQC7
1.94▼ 0.02 (-1.02%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
1.96
Day's Range
1.89 – 1.97
52-Week Range
1.43 – 3.24
Volume
148.0K
Avg Volume
205.6K
Share Statistics
Shares Outstanding
Employees
75
Exchange
XNAS
Listed
2000-08-11
Share count as of December 31, 2025

Compugen Ltd (CGEN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Compugen Ltd (CGEN)
What is Compugen Ltd's Market Cap?
Compugen Ltd's Market Cap is $183.4M, based on as-reported figures from SEC (XBRL) filings.
What is Compugen Ltd's Enterprise Value?
Compugen Ltd's Enterprise Value is $83.6M, based on as-reported figures from SEC (XBRL) filings.
What is Compugen Ltd's Trailing P/E?
Compugen Ltd's Trailing P/E is 5.2×, based on as-reported figures from SEC (XBRL) filings.
What is Compugen Ltd's Price / Sales?
Compugen Ltd's Price / Sales is 2.5×, based on as-reported figures from SEC (XBRL) filings.
What is Compugen Ltd's EV / Revenue?
Compugen Ltd's EV / Revenue is 1.1×, based on as-reported figures from SEC (XBRL) filings.
What is Compugen Ltd's EV / EBITDA?
Compugen Ltd's EV / EBITDA is 2.6×, based on as-reported figures from SEC (XBRL) filings.
What is Compugen Ltd's Revenue (TTM)?
Compugen Ltd's Revenue (TTM) is $72.8M, based on as-reported figures from SEC (XBRL) filings.
What is Compugen Ltd's Net Income (TTM)?
Compugen Ltd's Net Income (TTM) is $35.3M, based on as-reported figures from SEC (XBRL) filings.
What is Compugen Ltd's EBITDA?
Compugen Ltd's EBITDA is $31.8M, based on as-reported figures from SEC (XBRL) filings.
What is Compugen Ltd's Diluted EPS (TTM)?
Compugen Ltd's Diluted EPS (TTM) is 0.37, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CGENAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Revenue
YoY growth+161.1%
Cost of revenue
Gross profit
% of revenue87.3%
Operating expenses:
Research and development expenses, net
Marketing and business development expenses
General and administrative expenses
Total operating expenses
% of revenue44.2%
Operating profit (loss)
% of revenue43.1%
Financial and other income, net
Profit (loss) before taxes on income
Taxes on income, net
Net profit (loss)
% of revenue48.6%
Basic net profit (loss) per share
Diluted profit (loss) per ordinary share
Other comprehensive profit (loss):
Unrealized gain (loss) arising during the period from marketable securities
Total comprehensive profit (loss)